Chroma Medicine, Inc., a genomic medicine company advancing single-dose epigenetic editing therapeutics, has completed a $135 million Series B financing.…
Almaden Genomics has launched g.nome, a cloud-native platform designed to streamline genomic workflows and accelerate genomic discovery. Leveraging a visual…